Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model

Changes in the composition of glycans added to glycoproteins and glycolipids are characteristic of the change to malignancy. Sialyl-Tn (STn) is expressed by 25–30% of breast carcinomas but its expression on normal tissue is highly restricted. Sialyl-Tn is an O-linked disaccharide that can be carried...

Descripción completa

Detalles Bibliográficos
Autores principales: Julien, S, Picco, G, Sewell, R, Vercoutter-Edouart, A-S, Tarp, M, Miles, D, Clausen, H, Taylor-Papadimitriou, J, Burchell, J M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695689/
https://www.ncbi.nlm.nih.gov/pubmed/19436292
http://dx.doi.org/10.1038/sj.bjc.6605083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695689/
https://www.ncbi.nlm.nih.gov/pubmed/19436292
http://dx.doi.org/10.1038/sj.bjc.6605083

Ejemplares similares